Radiation improves long-term advantage in breast cancer:
This article was originally published in Clinica
Executive Summary
Providing high-risk breast cancer patients with radiation therapy in addition to chemotherapy, may add significant benefit than just chemotherapy alone. So finds a 20-year study, published in Journal of the National Cancer Institute (January 19), which observed that patients who received radiation therapy and adjuvant chemotherapy, compared to chemotherapy alone, had significant improvements in breast cancer survival (48%, versus 30%) and overall survival (47%, versus 37%). All 318 pre-menopausal women enrolled on the study had previously been treated with modified radical mastectomy and lymph node removal.
You may also be interested in...
Investors Go Beserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.